Uric Acid, Ferritin, Albumin, Parathyroid Hormone and Gamma-Glutamyl Transferase Concentrations are Associated with Uremic Cardiomyopathy Characteristics in Non-Dialysis and Dialysis Chronic Kidney Disease Patients

References

• Wang X, Shapiro JI. Evolving concepts in the pathogenesis of uraemic cardiomyopathy. Nat Rev Nephrol. 2019;15(3):159–175. doi:10.1038/s41581-018-0101-8
   PubMed Web of Science ®Google Scholar
• Chen S-C, Chang J-M, Liu W-C, et al. The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease. Hypertens Res. 2012;35(8):832–838. doi:10.1038/hr.2012.40
   PubMed Web of Science ®Google Scholar
• Garikapati K, Goh D, Khanna S, Echampati K. Uraemic cardiomyopathy: a review of current literature. Clin Med Insights Cardiol. 2021;23(15):1179546821998347.
   Web of Science ®Google Scholar
• Bao J-F, Hu -P-P, She Q-Y, Zhang D, Mo J-J LA, Li A. A bibliometric and visualized analysis of uremic cardiomyopathy from 1990 to 2021. Front Cardiovasc Med. 2022;9:908040. doi:10.3389/fcvm.2022.908040
   PubMed Web of Science ®Google Scholar
• Postorino M, Marino C, Tripepi G, Zoccali C. Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden. Kidney Int Suppl. 2008;74(Suppl 111):S64–S66. doi:10.1038/ki.2008.515
   Web of Science ®Google Scholar
• Liu J, Tian J, Chaudrhy M, et al. Attenuation of Na/K-ATPase mediated oxidant amplification with pNaKtide ameliorates experimental uremic cardiomyopathy. Sci Rep. 2017;20(7):46893. doi:10.1038/srep46893
   Web of Science ®Google Scholar
• Zawada AM, Carrero JJ, Wolf M, et al. Serum uric acid and mortality among haemodialysis patients. Kidney Int Rep. 2020;5:1196–1206. doi:10.1016/j.ekir.2020.05.021
   PubMed Web of Science ®Google Scholar
• Sukumaran A, Chang JC, Han M, Mintri S, Khaw B-A, Kim J. Iron overload exacerbates age-associated cardiac hypertrophy in a mouse model of hemochromatosis. Sci Rep. 2017;7(1):5756. doi:10.1038/s41598-017-05810-2
   PubMed Web of Science ®Google Scholar
• Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. 2011;124(20):2253–2263. doi:10.1161/CIRCULATIONAHA.111.050773
   PubMed Web of Science ®Google Scholar
• Shibata A, Ishima Y, Ikeda M, et al. Human serum albumin hydropersulfide is a potent reactive oxygen species scavenger in oxidative conditions such as chronic kidney disease. Biochem Biophys Res Commun. 2016;479(3):578–583. doi:10.1016/j.bbrc.2016.09.113
   PubMed Web of Science ®Google Scholar
• Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–1787. doi:10.1016/j.febslet.2008.04.057
   PubMed Web of Science ®Google Scholar
• Belinskaia DA, Veronina VI, Schmurak V, et al. The universal soldier: enzymatic and non-enzymatic antioxidant functions of serum albumin. Antioxidants. 2020;9(10):966. doi:10.3390/antiox9100966
   Web of Science ®Google Scholar
• Fujii H. Association between parathyroid hormone and cardiovascular disease. Ther Apher Dial. 2018;22(3):236–241. doi:10.1111/1744-9987.12679
   PubMed Web of Science ®Google Scholar
• Kim IY, Ye BM, Kim MJ, et al. Association between serum uric acid and left ventricular hypertrophy/left ventricular diastolic dysfunction in patients with chronic kidney disease. PLoS One. 2021;16(5):e0251333. doi:10.1371/journal.pone.0251333
   PubMed Web of Science ®Google Scholar
• Arenas MD, Soriano R, Andres M, Pascual E. Serum urate levels of hemodialyzed renal patients revisited. J Clin Rheumatol. 2021;27(8):e362–e366. doi:10.1097/RHU.0000000000001438
   PubMed Web of Science ®Google Scholar
• Ueda N, Takasawa K. Impact of inflammation on ferritin, hepcidin and the management of iron deficiency anemia in chronic kidney disease. Nutrients. 2018;10(9):1173. doi:10.3390/nu10091173
   PubMed Web of Science ®Google Scholar
• Gupta J, Dominic EA, Fink JC, et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study. PLoS One. 2015;10(4):e0124772. doi:10.1371/journal.pone.0124772
   PubMed Web of Science ®Google Scholar
• Settle LHBC, Lopes EPDA. Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review. Clinics. 2014;69(4):271–278. doi:10.6061/clinics/2014(04)09
   PubMed Web of Science ®Google Scholar
• Chen S, Sheng K, Shen Y, et al. Impact of parathyroidectomy on left ventricular function in end stage renal disease patients. BMC Nephrol. 2020;21(1):479. doi:10.1186/s12882-020-02139-3
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, Zhang YL. Castro 3rd AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Gunter S, Robinson C, Woodiwiss AJ, et al. Arterial wave reflection and subclinical atherosclerosis in rheumatoid arthritis. Clin Exp Rheumatol. 2018;36(3):412–420.
   PubMed Web of Science ®Google Scholar
• Hsu H-C, Norton GR, Peters F, et al. Association of post transplantation anaemia and persistent secondary hyperparathyroidism with diastolic function in stable kidney transplant recipients. J Nephrol Renovasc Dis. 2021;14:211–223. doi:10.2147/IJNRD.S314313
   PubMed Web of Science ®Google Scholar
• Bello H, Woodiwiss AJ, Naran R, et al. Impact of stroke work on the ability of left ventricular mass to account for pressure effects on function in a community with prevalent systemic flow-dependent hypertension. J Hypertens. 2021;39(10):2092–2102. doi:10.1097/HJH.0000000000002896
   PubMed Web of Science ®Google Scholar
• Santosh S, Chu C, Mwangi J, et al. Changes in pulmonary artery systolic pressure and right ventricular function in patients with end-stage renal disease on maintenance dialysis. Nephrology. 2019;24(1):74–80. doi:10.1111/nep.13183
   PubMed Web of Science ®Google Scholar
• Selem G, Stojceva-Taneva O, Tozija L, et al. Uric acid and left ventricular hypertrophy: another relationship in haemodialysis patients. Clin Kidney J. 2021;14(2):578–585. doi:10.1093/ckj/sfz172
   PubMed Web of Science ®Google Scholar
• Chiu T-H, Wu P-Y, Huang J-C, et al. Hyperuricemia is associated with left ventricular dysfunction and inappropriate left ventricular mass in chronic kidney disease. Diagnostics. 2020;10(8):514. doi:10.3390/diagnostics10080514
   Web of Science ®Google Scholar
• Luo Q, Xia X, Li B, Lin Z, Yu X, Huang F. Serum uric acid and cardiovascular mortality in chronic kidney disease: a meta-analysis. BMC Nephrol. 2019;20(1):18. doi:10.1186/s12882-018-1143-7
   PubMed Web of Science ®Google Scholar
• Dousdampanis P, Trigka K, Musso CG, Fourtounas C. Hyperuricemia and chronic kidney disease: an enigma yet to be solved. Ren Fail. 2014;36(9):1351–1359. doi:10.3109/0886022X.2014.947516
   PubMed Web of Science ®Google Scholar
• Murea M, Tucker BM. The physiology of uric acid and the impact of end-stage kidney disease and dialysis. Semin Dial. 2019;32(1):47–57. doi:10.1111/sdi.12735
   PubMed Web of Science ®Google Scholar
• Jia G, Habibi J, Bostick BP, et al. Uric acid promotes left ventricular diastolic dysfunction in mice fed a western diet. Hypertension. 2015;65(3):531–538. doi:10.1161/HYPERTENSIONAHA.114.04737
   PubMed Web of Science ®Google Scholar
• Rutherford E, Ireland S, Mangion K, et al. A randomized, controlled trial of the effect of allopurinol on left ventricular mass in haemodialysis patients. Kidney Int Rep. 2021;6(1):146–155. doi:10.1016/j.ekir.2020.10.025
   PubMed Web of Science ®Google Scholar
• Walter PB, Knutson MD, Paler-Martinez A, Lee S, Xu Y, Viteri FE. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad Sci USA. 2002;99(4):22649. doi:10.1073/pnas.261708798
   Web of Science ®Google Scholar
• Melenovsky V, Petrak J, Mracek T, et al. Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail. 2017;19(4):522–530. doi:10.1002/ejhf.640
   PubMed Web of Science ®Google Scholar
• Babitt JL, Eisenga MF, Haase VH, et al. Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) conference. Kidney Int. 2021;99(6):1280–1295. doi:10.1016/j.kint.2021.03.020
   PubMed Web of Science ®Google Scholar
• Macdougall IC, White C, Anker SD, et al. Intravenous iron in patients undergoing maintenance haemodialysis. N Engl J Med. 2019;380(5):447–458. doi:10.1056/NEJMoa1810742
   PubMed Web of Science ®Google Scholar
• Shah NR, Dumler F. Hypoalbuminaemia – a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV. Int J Med Sci. 2008;5(6):366–370. doi:10.7150/ijms.5.366
   PubMedGoogle Scholar
• Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996;7:728–736. doi:10.1681/ASN.V75728
   PubMed Web of Science ®Google Scholar
• Prenner SB, Pillutla R, Yenigalla S, et al. Serum albumin is a marker of myocardial fibrosis, adverse pulsatile hemodynamics, and prognosis in heart failure with preserved ejection fraction. J Am Heart Assoc. 2020;9(3):e014716. doi:10.1161/JAHA.119.014716
   PubMed Web of Science ®Google Scholar
• Gambardella J, De Rosa M, Sorriento D, et al. Parathyroid hormone causes endothelial dysfunction by inducing mitochondrial ROS and specific oxidative signal transduction modifications. Oxid Med Cell Longev. 2018;2018:9582319. doi:10.1155/2018/9582319
   PubMed Web of Science ®Google Scholar